Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

NCT00648349 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rabeprazole Sodium Delayed-Release Tablets 20 mg
DRUG: Aciphex® Delayed-Release Tablets 20 mg

Sponsor

Mylan Pharmaceuticals Inc